CytoSorbents’ $11.5 Million Shelf Takedown

Cooley advised the underwriters on CytoSorbents’ $11.5 million shelf takedown of 2,555,555 shares of common stock. Cowen and Company acted as the sole book-running manager for…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here